Flomoxef
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (6R,7R)-7-[[2-(Difluoromethylsulfanyl)acetyl]amino]-3- [[1-(2-hydroxyethyl)tetrazol-5-yl]sulfanylmethyl]- | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 99665-00-6  |
| ATC code | J01DC14 |
| PubChem | CID 65864 |
| UNII | V9E5U5XF42  |
| KEGG | D07963 |
| ChEMBL | CHEMBL15413 |
| Chemical data | |
| Formula | C15H18F2N6O7S2 |
| Mol. mass | 496.46 g/mol |
 (what is this?) (verify) |
|
Flomoxef (INN) is an oxacephem antibiotic.
It has been classified as second-generation[1] and fourth generation.[2]
References [edit]
- ^ Masuda Z, Kurosaki Y, Ishino K, Yamauchi K, Sano S (April 2008). "Pharmacokinetic analysis of flomoxef in children undergoing cardiopulmonary bypass and modified ultrafiltration". Gen Thorac Cardiovasc Surg 56 (4): 163–9. doi:10.1007/s11748-007-0208-5. PMID 18401677.
- ^ Ito M, Ishigami T (1991). "The meaning of the development of flomoxef and clinical experience in Japan". Infection. 19 Suppl 5: S253–7. PMID 1783441.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
